U.K. officials say they essentially lost more than £200 million ($308.9 million) buying up excess quantities of swine flu vaccine and antiviral meds. About a third of that loss occurred because unused vaccines weren't stored properly. And there's no secondary market for their surplus. "The worldwide surplus of swine flu vaccine means that there is no active market in which the department's excess pandemic flu inventory can be sold," health officials report. Story